# 3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects

> **NCT03103295** · PHASE1,PHASE2 · UNKNOWN · sponsor: **A.A. Partners, LLC** · enrollment: 20 (estimated)

## Conditions studied

- Bone Defects

## Interventions

- **BIOLOGICAL:** 3D-Tissue Engineered Bone Equivalent

## Key facts

- **NCT ID:** NCT03103295
- **Lead sponsor:** A.A. Partners, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11-20
- **Primary completion:** 2018-12-20
- **Final completion:** 2018-12-20
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03103295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03103295, "3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03103295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*